Literature DB >> 1689188

A new hereditary persistence of fetal hemoglobin deletion has the breakpoint within the 3' beta-globin gene enhancer.

C Camaschella1, A Serra, E Gottardi, A Alfarano, D Revello, U Mazza, G Saglio.   

Abstract

A new deletion of the beta-globin gene cluster has been characterized in two Italian brothers who are heterozygous carriers of a G gamma A gamma hereditary persistence of fetal hemoglobin (HPFH). Restriction endonuclease mapping and DNA sequencing of the region encompassing the breakpoint show that the deletion starts 3.2 kilobases (kb) upstream from the delta gene and ends within the enhancer region 3' to the beta-globin gene. Here the deletion removes one of the four binding sites for an erythroid specific transcriptional factor (NF-E1). The molecular comparison of the new deletion with others of similar size and location but associated with a delta beta-thalassemia phenotype suggests that the residual enhancer element, relocated near gamma genes, may increase the fetal hemoglobin (HbF) expression above the level observed in delta beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689188

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin.

Authors:  Urvashi Bhardwaj; Edward R B McCabe
Journal:  Mol Diagn       Date:  2005

2.  Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin.

Authors:  Khaimuk Changsri; Varaporn Akkarapathumwong; Duangporn Jamsai; Pranee Winichagoon; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

3.  Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.

Authors:  Lin Ye; Jiaming Wang; Yuting Tan; Ashley I Beyer; Fei Xie; Marcus O Muench; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Sequences in the (A)gamma-delta intergenic region are not required for stage-specific regulation of the human beta-globin gene locus.

Authors:  Karin M L Gaensler; Zemin Zhang; Chin Lin; Suya Yang; Karin Hardt; Linda Flebbe-Rehwaldt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 5.  Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.

Authors:  Vigneshwaran Venkatesan; Saranya Srinivasan; Prathibha Babu; Saravanabhavan Thangavel
Journal:  Mol Cell Biol       Date:  2020-12-21       Impact factor: 4.272

6.  Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.

Authors:  Annalisa Lattanzi; Vasco Meneghini; Giulia Pavani; Fatima Amor; Sophie Ramadier; Tristan Felix; Chiara Antoniani; Cecile Masson; Olivier Alibeu; Ciaran Lee; Matthew H Porteus; Gang Bao; Mario Amendola; Fulvio Mavilio; Annarita Miccio
Journal:  Mol Ther       Date:  2018-10-17       Impact factor: 11.454

7.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

8.  Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.

Authors:  R Calzolari; T McMorrow; N Yannoutsos; A Langeveld; F Grosveld
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

9.  Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.

Authors:  Sarah K Topfer; Ruopeng Feng; Peng Huang; Lana C Ly; Gabriella E Martyn; Gerd A Blobel; Mitchell J Weiss; Kate G R Quinlan; Merlin Crossley
Journal:  Blood       Date:  2022-04-07       Impact factor: 22.113

Review 10.  Concise Review: Epigenetic Regulation of Hematopoiesis: Biological Insights and Therapeutic Applications.

Authors:  Chiara Antoniani; Oriana Romano; Annarita Miccio
Journal:  Stem Cells Transl Med       Date:  2017-10-28       Impact factor: 6.940

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.